Simplex Trading, LLC Roivant Sciences Ltd. Transaction History

Simplex Trading, LLC

  • $195 Billion
  • Q3 2025

A detailed history of Simplex Trading, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Simplex Trading, LLC holds 45,228 shares of ROIV stock, worth $917,676. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,228
Previous 43,256 4.56%
Holding current value
$917,676
Previous $487,000 40.45%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$10.74 - $15.28 $21,179 - $30,132
1,972 Added 4.56%
45,228 $684,000
Q2 2025

Aug 05, 2025
SELL
$9.08 - $11.62 $662,367 - $847,655
-72,948 Reduced 62.78%
43,256 $487,000
Q1 2025

May 12, 2025
BUY
$10.09 - $12.08 $1.17 Million - $1.4 Million
116,204 New
116,204 $1.17 Million
Q3 2024

Nov 08, 2024
BUY
$10.17 - $12.5 $381,120 - $468,437
37,475 New
37,475 $432,000
Q1 2024

Apr 25, 2024
SELL
$9.87 - $11.8 $638,431 - $763,271
-64,684 Reduced 54.49%
54,030 $569,000
Q4 2023

Feb 02, 2024
BUY
$8.38 - $11.58 $972,155 - $1.34 Million
116,009 Added 4288.69%
118,714 $1.33 Million
Q3 2023

Nov 01, 2023
BUY
$9.76 - $13.19 $26,400 - $35,678
2,705 New
2,705 $31,000
Q3 2022

Nov 04, 2022
SELL
$0.51 - $4.84 $12,272 - $116,469
-24,064 Reduced 60.23%
15,890 $51,000
Q2 2022

Aug 03, 2022
BUY
$2.81 - $4.84 $82,703 - $142,450
29,432 Added 279.72%
39,954 $162,000
Q1 2022

May 02, 2022
BUY
$4.74 - $9.91 $49,874 - $104,273
10,522 New
10,522 $51,000

Others Institutions Holding ROIV

# of Institutions
373
Shares Held
436M
Call Options Held
6.05M
Put Options Held
2.52M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $14.3B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email